Every year, up to one million children in the U.S. with persistent ear infections (otitis media) or middle ear fluid collections (effusions) undergo placement of metal, plastic or latex bilateral ear tubes to ventilate and drain the middle ear, with 20%-50% of cases requiring repeat surgery. PAVmed holds an exclusive worldwide license to develop and commercialize antibiotic-eluting resorbable ear tubes, made from a new proprietary bioabsorbable silk material. The device does not require a second general anesthesia procedure for tube removal, nor does it require a difficult-to-administer post-procedure antibiotic ear drop regimen. In addition, there is less chance of the tubes falling into the middle ear and a reduced risk of permanent perforation.
This product is in the development phase and has yet to receive regulatory approval.